Style | Citing Format |
---|---|
MLA | Mohebbi A, et al.. "A Fragment-Based Drug Discovery Developed on Ciclopirox for Inhibition of Hepatitis B Virus Core Protein: An in Silico Study." PLoS ONE, vol. 18, no. 5 May, 2023, pp. -. |
APA | Mohebbi A, Ghorbanzadeh T, Naderifar S, Khalaj F, Askari FS, Salehnia Sammak A (2023). A Fragment-Based Drug Discovery Developed on Ciclopirox for Inhibition of Hepatitis B Virus Core Protein: An in Silico Study. PLoS ONE, 18(5 May), -. |
Chicago | Mohebbi A, Ghorbanzadeh T, Naderifar S, Khalaj F, Askari FS, Salehnia Sammak A. "A Fragment-Based Drug Discovery Developed on Ciclopirox for Inhibition of Hepatitis B Virus Core Protein: An in Silico Study." PLoS ONE 18, no. 5 May (2023): -. |
Harvard | Mohebbi A et al. (2023) 'A Fragment-Based Drug Discovery Developed on Ciclopirox for Inhibition of Hepatitis B Virus Core Protein: An in Silico Study', PLoS ONE, 18(5 May), pp. -. |
Vancouver | Mohebbi A, Ghorbanzadeh T, Naderifar S, Khalaj F, Askari FS, Salehnia Sammak A. A Fragment-Based Drug Discovery Developed on Ciclopirox for Inhibition of Hepatitis B Virus Core Protein: An in Silico Study. PLoS ONE. 2023;18(5 May):-. |
BibTex | @article{ author = {Mohebbi A and Ghorbanzadeh T and Naderifar S and Khalaj F and Askari FS and Salehnia Sammak A}, title = {A Fragment-Based Drug Discovery Developed on Ciclopirox for Inhibition of Hepatitis B Virus Core Protein: An in Silico Study}, journal = {PLoS ONE}, volume = {18}, number = {5 May}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Mohebbi A AU - Ghorbanzadeh T AU - Naderifar S AU - Khalaj F AU - Askari FS AU - Salehnia Sammak A TI - A Fragment-Based Drug Discovery Developed on Ciclopirox for Inhibition of Hepatitis B Virus Core Protein: An in Silico Study JO - PLoS ONE VL - 18 IS - 5 May SP - EP - PY - 2023 ER - |